Jakob Loven

Jakob Loven

Directeur/Membre du Conseil chez
Arvinas Operations, Inc.
48 ans
Health Technology
Consumer Services
Finance

Profil

Jakob Loven was the founder of Syros Pharmaceuticals, Inc. (2013) and Relay Therapeutics, Inc. (2015) with the title of Senior Director-Business Development & Strategy.
Current jobs include Director at Arvinas Operations, Inc., Director at Arrakis Therapeutics, Inc., Director at A2 Biotherapeutics, Inc., Director at IconOVir Bio, Inc., Director at Flare Therapeutics, Inc., Director at Hexagon Bio, Inc., and Partner at Nextech Invest AG.
Former jobs include Director at Turning Point Therapeutics, Inc. (2018-2019), Independent Director at Arvinas, Inc. (2018-2020), Director at Vividion Therapeutics, Inc., Independent Director at Kronos Bio, Inc., Director at Kinnate Biopharma, Inc. (2019-2020), Director at Autolus Therapeutics Plc, Independent Director at Boundless Bio, Inc., and Senior Associate at Third Rock Ventures LLC (2015-2016).
Education includes a doctorate from Karolinska Institutet (2010) and an undergraduate degree from the University of Anglia Ruskin (2002).

Postes actifs de Jakob Loven

SociétésPosteDébut
Private Equity Investor 01/08/2017
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Directeur/Membre du Conseil 22/04/2019
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -
Directeur/Membre du Conseil -

Anciens postes connus de Jakob Loven

SociétésPosteFin
KRONOS BIO, INC. Directeur/Membre du Conseil 22/06/2021
KINNATE BIOPHARMA INC. Directeur/Membre du Conseil 01/12/2020
░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░ ░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Jakob Loven

Formation de Jakob Loven

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

40

Relations au 1er degré

19

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées19

Health Technology

Health Technology

Consumer Services

Finance

Finance

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Jakob Loven